ScoreWhy is Sanofi Consumer Healthcare India Ltd ?
1
With ROE of 83.6, it has a Very Expensive valuation with a 42 Price to Book Value
- Over the past year, while the stock has generated a return of -2.57%, its profits have fallen by -27%
2
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -2.57% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Sanofi Consumer for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Sanofi Consumer
-3.12%
-0.11
27.75%
Sensex
4.83%
0.41
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
95.70%
EBIT Growth (5y)
83.94%
EBIT to Interest (avg)
90.90
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.73
Sales to Capital Employed (avg)
2.33
Tax Ratio
25.53%
Dividend Payout Ratio
69.89%
Pledged Shares
0
Institutional Holding
20.15%
ROCE (avg)
-202.82%
ROE (avg)
76.98%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
50
Industry P/E
34
Price to Book Value
41.95
EV to EBIT
38.95
EV to EBITDA
37.66
EV to Capital Employed
154.87
EV to Sales
13.27
PEG Ratio
NA
Dividend Yield
1.17%
ROCE (Latest)
368.27%
ROE (Latest)
83.61%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend15What is working for the Company
PAT(Q)
Highest at Rs 62.90 cr.
NET SALES(Q)
At Rs 233.90 cr has Grown at 29.2% (vs previous 4Q average
PBDIT(Q)
Highest at Rs 85.00 cr.
PBT LESS OI(Q)
At Rs 81.10 cr has Grown at 31.2% (vs previous 4Q average
EPS(Q)
Highest at Rs 27.35
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Sanofi Consumer
Net Sales - Quarterly
Highest at Rs 233.90 cr and Grown
each quarter in the last five quartersMOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 81.10 cr. and Grown
each quarter in the last five quartersMOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 62.90 cr. and Grown
each quarter in the last five quartersMOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Net Sales - Quarterly
At Rs 233.90 cr has Grown at 29.2% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 181.03 CrMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 85.00 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 81.10 cr has Grown at 31.2% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 61.80 CrMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 62.90 cr has Grown at 27.2% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 49.46 CrMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 27.35
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
